Clinical Cell Culture (C3) is a company listed on the Australian Stock Exchange (ASX Code CCE) that was established to commercialise a number of autologous tissue engineered products for autologous cell replacement. C3 is able to provide culture services from laboratories based in Australia and Europe and is expanding their sales, marketing and clinical support programme throughout the world. This has been achieved by employing expert staff in Australia and Europe who are recruiting specialised distributors globally. Whilst now a commercial entity with operations in Asia-Pacific and Europe, C3 remains committed to the further development of autologous tissue technologies. Ongoing research will result in a pipeline of innovative products that will be used to optimise patients' outcomes. The use of collaborations with key research groups such as the McComb Foundation will ensure C3 research remains at the forefront of technology. C3 is also committed to providing the highest level of continuing medical education and clinical support to enable the appropriate use of C3's tissue engineered products.
View Top Employees from Clinical Cell Culture LtdWebsite | http://www.clinicalcellculture.com |
Revenue | $6.2 million |
Employees | View employees |
Address | Unit 5 6 Brodie Hall Dr, Bentley, Western Australia 6102, AU |
Industry | Retail |
SIC | SIC Code 80 Companies, SIC Code 807 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies |
Looking for a particular Clinical Cell Culture Ltd employee's phone or email?
The Clinical Cell Culture Ltd annual revenue was $6.2 million in 2024.
Clinical Cell Culture Ltd is based in Bentley, Western Australia.
The NAICS codes for Clinical Cell Culture Ltd are [6215, 62, 62151, 621].
The SIC codes for Clinical Cell Culture Ltd are [80, 807].